EBSA voices author

Patrick Rüdelsheim

Trained as a biologist, Patrick Rüdelsheim started his career in a Dutch seed company. He then joined Plant Genetic Systems N.V., Ghent, Belgium. After being in charge of Product Development and Registration, he was appointed Director Regulatory Affairs and Member of the Board. 

Following the acquisition of PGS, he became Global Head of Biotechnology Regulatory Affairs for the AgrEvo group and remained in this function during the subsequent creation of Aventis S.A. and the acquisition by Bayer. In this function, he ensured the scientific argumentation for Product Safety and Quality as well as the compliance with all regulatory acquirements related to genetic engineering.

In 2003, he founded and became General Manager of Perseus BV, a service company focused on bio-safety and related regulatory requirements. Mid 2015, he was co-founder and served as Senior Regulatory Advisor for ABS-int, a multi-disciplinary initiative dedicated to Access and Benefit Sharing requirements for genetic resources. Since 2023, Perseus and ABS-int operate together as 3Bio, in which he acts as Director and Chief Regulatory Officer. In this capacity he offers his extensive and global experience in every aspect of biosafety and biotechnology regulation to a range of users and developers. He lectures on biosafety and regulations at the University of Ghent and the University of Antwerp.

  1. Keeping pace with synthetic biology: the Convention on Biological Diversity in 2026

    The Convention on Biological Diversity came into force on 29 December 1993, but it has never stood still. Through its Conference of the Parties and supporting scientific bodies, the Convention keeps watch over how its 196 Parties are putting it into practice, and tracks new scientific, technological and policy developments around the world. That means looking ahead too - to synthetic biology, digital sequence information and other frontier biotechnologies - so the Convention can keep pace with the issues it was set up to handle. As far back as 2010, the Parties invited governments, organisations and other interested groups to share information on synthetic biology with the Convention's scientific advisory body, while urging caution about releasing any synthetic life, cell or genome into the environment.

    Read more about "Keeping pace with synthetic biology: the Convention on Biological Diversity in 2026"

Disclaimer Notice

The publications, articles, and other materials featured on this webpage are provided by individual members of EBSA. The views, opinions, and positions expressed in these contributions are solely those of the respective authors and do not necessarily reflect the official policy, position, or views of EBSA.

EBSA does not endorse, approve, or take responsibility for the accuracy, completeness, or reliability of any content published by its members. Any references to specific products, services, or organizations are made by the authors in their personal capacity and do not constitute endorsement or recommendation by EBSA.

Readers are encouraged to exercise their own judgment and critical thinking when engaging with the content provided on this platform.